If this box remains here for more than 30 seconds, click this link to try again.
Products & Services »
Medical Affairs » Medical Science Liaison
Download FREE Excerpt
15 Info Graphics
47 Data Graphics
Single User: Authorizes use by the person who places the order or for whom the order was placed.
Sitewide: Authorizes use of the report for a geographic site. All people at site can view the report for a year and copies can be printed.
Corporate: Authorizes use for the entire company for a year and copies can be printed. No limitations for usage inside the company.
Pharmaceutical; Biopharmaceutical; Biotech; Manufacturing; Consumer Products; Diagnostic; Medical Device; Health Care; Chemical
AbbVie; AcelRx; Alkermes; Allergan; Allergopharma; Amgen; Astellas; AstraZeneca; Bayer; Biogen; Chiesi; Cooper Surgical; Daiichi Sankyo; Eisai; EMD Serono; Ferring Pharmaceuticals; Gedeon Richter ; Genentech; GlaxoSmithKline ; Ipsen; Janssen; Kyowa Kirin; Merck; Merck KGaA; Novartis; Novelion Therapeutics; Novo Nordisk; Pfizer; Roche; Shire; Sunovion; UCB Pharma; Vertex Pharmaceuticals; Vifor Pharma; ViiV Healthcare; ZS Pharma
Best Practices, LLC engaged 55 medical affairs and field-based medical team leaders from a total of 36 top pharma and biotech organizations through a benchmarking survey. Six deep-dive interviews were conducted with medical affairs leaders, whose insights were provided to enrich the data and add real-world context to the metrics and trends established.
To offer clear understanding of field medical trends across major markets, benchmark data is segmented by: Total Benchmark Class (N=69); Global Market Segment, excluding U.S. (N=38); North America Market Segment (N=31); Europe (EU5) Market Segment (N=24); and JAPAC Market Segment (N=5).
Key topics covered in this report include: